Estrogen-mediated ubiquitylation and subsequent degradation of the estrogen receptor (ER ) appears to be involved in the transcriptional activity of ER . We show that the estrogen-responsive finger protein (EFP) interacts with and ubiquitylates ER . EFP promoted the ubiquitylation of ER in vitro and in vivo and consequently promoted the degradation of ER . The interaction between EFP and ER was greatly enhanced in the presence of estrogen. The action of EFP on ER in the presence of estrogen resulted in a robust interaction between ER and Tip60, one of the transcriptional coactivators, leading to activation of ER transcriptional activity.
Introduction
Estrogen is a hormone that plays crucial roles in cell growth and differentiation and in regulation of the female reproductive system. The multifunctional effects of estrogen are elicited through interaction with the estrogen receptor (ER). ER and ER belong to the steroid hormone superfamily of nuclear receptors, which act as ligand-dependent transcriptional factors [1] . Native unliganded ER occurs in complex with the molecular chaperone Hsp90 and cochaperones, contributing to maintenance of the receptor stability. When bound to estrogen, ER undergoes conformational changes, dissociations from heat shock proteins, a receptor dimerization, DNA bindings at the estrogen responsive element (ERE) of the target, interactions with coactivators, and the subsequent recruitment of transcription factors to be formed by either up-regulation or down-regulation of target gene transcription [2] . A number of coactivators of nuclear receptors have been identified, including members of the p160 family (SRC-1, TIF-2 and SRC-3), p300/CBP and Tip60, which exhibit histone acetyltransferase activities and recruit components of the general transcription machinery [3, 4] .
Furthermore, the involvement of ubiquitin-proteasome components in ER -mediated transcription has been suggested by the results of studies utilizing proteasome inhibitors [5] . Upon treatment of cells with 17 -estradiol, ubiquitylation of ER is enhanced and the degradation of ER by a proteasome-dependent proteolytic pathway is required for efficient ER transactivation [6] . Ubiquitin conjugation is catalyzed by enzymes designated as ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3). The resulting covalent ubiquitin ligations form polyubiquitylated conjugates that are rapidly detected and degraded by 26S proteasome. E3 has so far been shown to include members of the HECT (homologous to E6-AP carboxyl terminus), RING-finger, and U-box families of proteins [7] [8] [9] .
Here we provide evidence that the estrogen-responsive finger protein (EFP) promotes the ubiquitylation and proteasome-mediated degradation of liganded ER . We show that EFP binds to and ubiquitylates ER to activate transcription, suggesting that EFP may function as a cofactor for ER -induced transcription.
Materials and methods
Cell culture. HEK293T and HeLa cells (ATCC) were cultured under an atmosphere of 5% CO 2 at 37°C in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal bovine serum (Invitrogen). MCF-7 cells (ATCC) were cultured under the same conditions with 0.01 mg/ml insulin (Sigma).
Cloning of cDNAs and plasmid construction. Human EFP and ER cDNAs were amplified from MCF-7 cDNA by the polymerase chain reaction (PCR) with KOD plus (TOYOBO) using primers 5'-GCCATGGCAGAGCTGTGCCCCCTG-3' (EFP-sense),
5'-ATGACCATGACCCTCCACACCAAA-3' (ER -sense), and 5'-TCAGACTGTGGCAGGGAAACCCTC-3' (ER -antisense). The amplified fragments were subcloned into pBluescript II SK + (Stratagene). The FLAG-tagged EFP cDNA and FLAG-or HA-tagged ER cDNA were then subcloned into pCGN, pcDNA3 (Invitrogen), pFastBacHT (Invitrogen), pBTM116 and pACT2 (Clontech).
Site-specific mutagenesis was performed with a Quick Change kit (Stratagene). Human
Tip60 cDNA was obtained from Dr. Ikura (Tohoku University). The deleted mutants of ER cDNA were generated by PCR.
Baculovirus expression system. The plasmids pFastBacHT containing the relevant cDNAs were subjected to recombination with the baculoviral genome in DH10BAC, and the resulting recombinant viral genome was introduced into Sf9 cells by transfection in order to generate recombinant baculoviruses.
Transfection, immunoprecipitation, and immunoblot analysis. HEK293T cells were
transfected by the calcium phosphate method [9] . Immunoblot analysis was performed with the following primary antibodies: anti-c-Myc (1 μg/ml; 9E10, Covance),
anti-FLAG (1 μg/ml; M2 or M5, Sigma), anti-HA (1 μg/ml; HA.11/16B12, Babco),
anti-hexa-histidine (1 μg/ml; H-15, Santa Cruz), anti-Hsp90 (1 μg/ml; 68, TDL),
anti-EFP (1 μg/ml; 2, TDL), anti-ubiquitin (1 μg/ml; P4D1, Santa Cruz) and anti-ER
(1 μg/ml; H-184, Santa Cruz).
In vitro pull-down assay. Recombinant His 6 -EFP (0.5 μg) and recombinant His 6 -ER (0.5 μg) were mixed in 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 1%
Nonidet P-40 for 1 h at 4°C. The binding mixtures were incubated with anti-EFP antibody for 1 h at 4°C. Protein G-Sepharose, which was equilibrated with the same solution, was added to the mixture and then rotated for 1 h at 4°C. The resin was separated by centrifugation, washed five times with lysis buffer, and then boiled in SDS sample buffer. Immunoblot analysis was performed with anti-ER antibody.
-galactosidase assay using yeast two-hybrid system. -galactosidase assays were performed as previously described [10] . Incubations were allowed to proceed for 5 h at 30°C and then the OD 420 was taken to calculate the -galactosidase activity using the following equation: 1000 OD 420 /(t x V x OD 600 ), where t is the elapsed time (min) and V is 0.1 ml x concentration factor (concentration factor = 5 in this experiment).
In vitro ubiquitylation assay. An in vitro ubiquitylation assay was performed as previously described. Reaction mixtures were incubated for 2 h at 30°C and then subjected to immunoblot analysis with a mouse monoclonal antibody to ubiquitin or ER [11] . 
Results

Interaction of EFP with ER
The Efp gene has been reported to have an ERE, and its mRNA is actually induced by estrogen treatment [12] . We investigated whether EFP physically interacts with ER .
We expressed FLAG-tagged EFP, together with/without hemagglutinin epitope (HA)-tagged ER , in HEK293T cells. Cell lysates were subjected to immunoprecipitation with an antibody to FLAG, and the resulting precipitates were subjected to immunoblot analysis with an antibody to HA or FLAG. HA-ER was co-precipitated by the antibody to FLAG in the presence of FLAG-EFP (Fig. 1A) . To examine the interaction by an in vitro pull down assay, we generated and purified recombinant hexahistidine epitope (His 6 )-tagged EFP and ER. The recombinant His 6 -EFP was mixed with His 6 -ER and then immunoprecipitated with an antibody to EFP, and the resulting precipitates were subjected to immunoblot analysis with an antibody to ER or EFP. His 6 -ER was selectively co-precipitated by the antibody to EFP in the presence of His 6 -EFP (Fig. 1B) . These results suggest that EFP specifically interacts with ER . To quantify the affinity between EFP and ER in the presence or absence of estrogen (17 -estradiol), we used a yeast two-hybrid system. EFP interacted weakly with ER in a yeast two-hybrid assay in the absence of estrogen but interacted strongly with ER in the presence of estrogen (Fig. 1C ). Next we examined the ligand dependency of this interaction by using the mammalian cell line MCF-7 that endogenously expressed ER . It has been reported that 17 -estradiol causes proteasome-dependent degradation of ER [13] . Thus, we investigated whether endogenous EFP interacts with endogenous ER in MCF-7 cells in the presence of the proteasome inhibitor MG132. A small amount of ER was detected in the immunoprecipitation performed with an anti-EFP antibody in the presence of 17 -estradiol but not in the immunoprecipitation with an anti-HA antibody as a negative control (Fig. 1D ). The combination of 17 -estradiol and MG132 more greatly enhanced the endogenous interactions in vivo (Fig. 1D ). These results suggest that estrogen contributes to the interaction between EFP and ER in MCF-7 cells.
To identify the region of ER responsible for the interaction with EFP, a series of ER deletion derivatives were generated (Fig. 1E) . Deletion of the N-terminal 296 amino acids (ER (297-595)) did not affect the binding to EFP, whereas the deletion of C-terminal 255 amino acids (ER (1-340)) abolished the binding to EFP. The region containing amino acids 297-534 of ER , not comprising the coactivator binding region in AF-2, is required for the interaction with EFP (Fig. 1F) .
Ubiquitin ligase activity of EFP
To determine whether EFP has an E3 ligase activity, we performed in vitro ubiquitylation assays. Immunoblot analysis of the reaction mixtures with antibodies to ubiquitin and EFP revealed the ubiquitylation of His 6 -EFP only in the presence of E1, E2 (UbcH5C), ubiquitin, ATP, and EFP itself ( Fig. 2A) . The lack of any of these components prevented self-ubiquitylation of EFP. EFP was thus shown to be a bona fide E3 ligase.
To further investigate the region of EFP responsible for ubiquitylation, a deletion mutant lacking the RING domain ( RING) and a RING domain mutant in which the first cysteine was substituted by alanine (C8A) were generated (Fig. 2B) . In vitro ubiquitylation assays indicated that an intact RING domain is indispensable for E3 ligase activity of EFP (Fig. 2C ).
To analyze the class of polyubiquitin chains supported by E3 ligase activity of EFP, three mutant ubiquitins in which lysine was substituted by arginine at position 48 and/or 63, namely UbK48R, UbK63R and UbK48/63R, were purified. According to in vitro ubiquitylation assays, EFP underwent polyubiquitylation with UbK63R but not with UbK48R or UbK48/63R, implying that EFP predominantly uses the lysine at position 48 on ubiquitin for the formation of a polyubiquitylation chain ( Fig. 2D and E). To further confirm polyubiquitylation of EFP through K48-based chains, recombinant proteins of mutants UbK48 and UbK63, each having one lysine residue at positions 48 and 63, respectively, and all other lysines substituted by arginine, were generated. EFP mediated the polyubiquitylation by UbK48 but not by UbK63, indicating the lysine at position 48 on ubiquitin is sufficient for the formation of a polyubiquitylation chain by EFP (Fig. 2E) .
EFP ubiquitylates ER in vitro and in vivo
To determine whether EFP ubiquitylates ER , we assayed E3 ligase activity of His 6 -EFP against His 6 -ER . Polyubiquitylation of His 6 -ER was observed only in the additional presence of the His 6 -EFP (Fig. 3A) . However, polyubiquitylation of ER was not detected in the presence of EFP(C8A) (Fig. 3B) . To further investigate the ubiquitylation of ER in cells by in vivo ubiquitylation assay, FLAG-ER , EFP and HA-ubiquitin were expressed in HEK293T cells. FLAG-ER was ubiquitylated extensively when cotransfected with EFP (Fig. 3C) .
To examine the possible effect of EFP on the degradation of ER in vivo, we transfected HEK293T cells with vectors for HA-ER and for FLAG-EFP or FLAG-EFP( RING) as a dominant negative form. Pulse-chase analysis in the presence of estrogen revealed that the expression of EFP exhibits the degradation of ER , whereas overexpression of EFP( RING) delays the degradation of ER ( Fig. 3D and E) .
These results thus suggest that EFP contributes to the turnover of ER in cells.
EFP enhances activation of transcription by ER
To examine the effect of EFP on ER -induced transcription in MCF-7 cells, we collaboration with other coactivators, p300/CBP [15] . It has been reported that Skp2 binds to c-Myc and thereby mediates its ubiquitylation. Skp2 also increases the transcriptional activity of c-Myc, suggesting that Skp2 is a transcriptional cofactor [16] .
Moreover, it has been shown that HectH9-mediated ubiquitylation of Myc is required for transactivation of multiple target genes by recruitment of the coactivator p300 [17] .
EFP-mediated ER ubiquitylation may be crucial for recruitment of the transcriptional cofactors as well.
It has been shown that Efp-/-mice of both sexes were viable and fertile and that the uterus, which expressed a high level of ER in wild-type mice, exhibited significant underdevelopment [18] . We have demonstrated that the transcriptional activation of ER is enhanced by EFP. Therefore, these phenotypes of Efp-/-mice can be explained by the balance of interaction between EFP and ER .
Recently, another E3 ligase, CHIP, has been reported to induce ubiquitylation of unliganded ER , and CHIP probably degrades unfolded and misfolded ER to maintain quality control of ER in the cytoplasm [19] . The ubiquitylation of ER by CHIP is independent of estrogen and serves for the degradation of misfolded ER . EFP ubiquitylates ER dependent on estrogen to up-regulate its transcriptional activity.
These findings demonstrate that the role of EFP is different from that of CHIP with regards to the ubiquitylation of ER . Tip60:
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